ALDH4A1
ALDH4A1proteinALDH4A1 autoimmunity marks atherosclerotic plaque instability and fibrous-cap erosion.
Pathway placement
Cascade stepFibrous-cap degradation & rupture
Confidencemedium
RationalePlaque autoantigen and erosion biomarker; associates with cap degradation.
Also acts inVascular inflammation
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableNo
EnsemblENSG00000159423
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(2)
- Atherosclerotic Autoantigen ALDH4A1 as a Novel Immunological Indicator for Plaque Erosion in Patients with ST Segment Elevated Myocardial Infarction.Thrombosis and haemostasis · 2023 · PMID 38109905 · doi
- ALDH4A1 is an atherosclerosis auto-antigen targeted by protective antibodies.Nature · 2020 · PMID 33268892 · doi